SUBCELLULAR LOCALIZATION
| extracellular
|
| plasma membrane
|
| intracellular
|
| intracellular,cytoplasm,organelle,endoplasmic reticulum
|
| intracellular,cytoplasm,organelle,Golgi
|
| intracellular,cytoplasm,organelle,endosome
|
| intracellular,cytoplasm,organelle,lysosome
|
text
| although ligand recognition occurs in endolysosomes, it has been reported that most, if not all, TLR9 resides in the endoplasmic reticulum (ER) of resting cells |
|
sequestered in the endoplasmic reticulum (ER) in a resting state and traffic to endolysosomes upon ligand-induced stimulation |
|
translocates from ER to endolysosomes through the Golgi complex and that Golgi export is required for optimal TLR9 signaling |
|
primarily resides in the endoplasmic reticulum, traffics to endosomes, is proteolytically processed and responds to DNA |
|
expressed on the surface of splenic dendritic cells |
|
localized in the endolysosome |
basic FUNCTION
| pathogen recognition and activation of innate immunity |
|
potential inducer of apoptosis and septic shock |
|
activating NF-Kappa B signaling pathway |
|
can recognize nucleic acids and trigger signaling cascades that activate plasmacytoid dendritic cells to produce interferon-alpha (thus contributing to the pathogenesis of systemic lupus erythematosus) |
|
mediating cellular response to unmethylated CpG dinucleotides in bacterial DNA to mount an innate immune response |
|
required for effective innate immune responses against Gram-negative bacterial pathogens |
|
blocks osteoclast differentiation through induction of phosphatase |
|
initiate immune responses to infection by recognizing microbial nucleic acid |
|
requirement for processing of TLR9 may represent an evolutionary strategy to ensure proper self/non-self discrimination based on nucleic acid recognition |
|
recognize pathogen-derived nucleotides in intracellular compartments and respond to host-derived nucleotides as well, and they have been implicated in a variety of autoimmune diseases |
|
TLR9-induced suppression of EBV lytic gene expression is dependent on the TLR9–MyD88 signaling axis |
|
TLR9–MyD88 activation leading to histone modification might be the signaling event responsible for the interaction between the malaria parasite P. falciparum and EBV gene expression in B cells contributing to the pathogenesis of endemic Burkitt lymphoma |
|
with TLR7, are required for plasmacytoid dendritic cells |
|
senses DNA with unmethylated CpG motifs derived from bacteria and viruses |
|
TLR9 signaling pathway is involved in inflammatory responses in failing hearts in response to pressure overload and plays an important role in the pathogenesis of heart failure |
|
mitochondrial DNA that escapes from autophagy-mediated degradation cell-autonomously leads to TLR9-mediated inflammatory responses in cardiomyocytes, myocarditis, and dilated cardiomyopathy |
|
cell death and injury result in the release of mtDNA (mitochondrial DNA) that acts via TLR9 (Toll-like receptor 9), a pattern recognition receptor of the immune system which detects bacterial and viral DNA |
|
platelet TLR9 is a functional platelet receptor that links oxidative stress, innate immunity, and thrombosis |
|
TLR9-mediated recognition of viral and bacterial DNA activates the innate immune system |
|
would potentially signal in acidic pH as endolysosome/lysosome condition |
|
has paradoxical roles in regulating anti-DNA B cells |
|
initiates inflammatory response by recognizing DNA, imported by infection or released from tissue damage |
|
role of TLR9 in energy metabolism and cellular protection in cardiomyocytes and neurons |
|
component of the innate immune system, which recognizes the DNA of both pathogens and hosts, and can drive autoimmune diseases |
|
TLR7 plays a central role in early immune activation during malaria infection, whereas TLR7 and TLR9 contribute combinatorially to immune responses as infection progresses |
|
distinct roles for TLR7 and TLR9 in the differentiation of autoreactive B cells that explain the capacity of TLR9 to limit, as well as TLR7 to promote, the clinical features of systemic erythematosus lupus |